Latest Memorial Sloan–Kettering Cancer Center Stories
Scientific investigators at five institutions receive $1 million to spur better outcomes for patients with acral melanoma and provide breakthroughs through the use of genome sequencing.
For the first time, a genetic link specific to risk of childhood leukemia has been identified.
Hands On HealthCare Massage Therapy and Wellness Day Spa is raising awareness and funds during September, National
On September 27, the Mesothelioma Applied Research Foundation will be the host of its “Knowledge is Hope” regional conference on malignant mesothelioma, taking place at the Harvard Club in
A new study by thoracic surgeons and pathologists at Memorial Sloan-Kettering Cancer Center shows that a specific pattern found in the tumor pathology of some lung cancer patients is a strong predictor of recurrence.
The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma.
- To give a box on the ear to.